The insider sales are too small to warrant a bearish read-through. Monitor the XOMA acquisition closing (Q3 2026) and upcoming quarterly filings for any change in insider selling patterns. The strong Q1 royalty growth and raised guidance support the current bullish analyst consensus (93% buy).
Price Chart
Executive Summary
Director John Kozarich and CLO Andrew Reardon sold a combined $155K in open-market sales on May 1, 2026, following Ligand's strong Q1 earnings (royalty revenue +56% YoY) and the reaffirmation of raised 2026 guidance tied to the pending XOMA acquisition. The sales are small relative to the $4.4B market cap (0.0035%) and likely reflect routine portfolio rebalancing or tax planning, not a bearish signal on fundamentals.
Key Financial Metrics
Key Facts
- Two insiders sold a total of 680 shares for $155K on May 1, 2026.
- Sales represent ~0.0035% of Ligand's $4.4B market cap — trivial in size.
- Director Kozarich also exercised and sold shares on May 12-13, 2026, in a separate cluster ($455K total).
- Q1 2026 earnings showed royalty revenue up 56% YoY to $43M; adjusted EPS of $1.63 beat prior year's $1.33.
- Ligand reaffirmed raised 2026 guidance: adjusted EPS $8.50-$9.50, royalty revenue $225M-$250M.
- Pending XOMA acquisition ($39/share cash + CVR) expected to close in Q3 2026.
Financial Impact
Insider sales of $155K are immaterial relative to $4.4B market cap.
Risk Factors
- Pending XOMA acquisition may face stockholder approval or regulatory delays.
- Captisol sales declined 36% YoY in Q1 2026 due to customer order timing.
- Non-cash loss on Pelthos investment ($49.2M) drove GAAP net loss of $13.3M.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-LGND-1778807348557 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 17d ago | Insider Cluster | $276.98 $298.50 | ▲ +7.77% | ▲ +5.66% | $301.83 (+8.97%) |
Aug 14, 2026 6w ago | Insider Cluster | $291.77 $280.18 | ▼ −3.97% | ▼ −2.78% | $301.83 (+3.45%) |
Aug 6, 2026 8w ago | 8-K | $300.14 $288.82 | ▼ −3.77% | ▼ −4.98% | $301.83 (+0.56%) |
Jun 25, 2026 14w ago | 8-K | $303.59 $319.55 | ▲ +5.26% | ▲ +3.09% | $301.83 (−0.58%) |
Jun 18, 2026 15w ago | Insider Cluster | $274.88 $295.92 | ▲ +7.65% | ▲ +9.32% | $301.83 (+9.80%) |
Jun 16, 2026 15w ago | Insider Cluster | $255.25 $279.44 | ▲ +9.48% | ▲ +11.71% | $301.83 (+18.25%) |
Jun 12, 2026 15w ago | Insider Cluster | $253.25 $262.17 | ▲ +3.52% | ▲ +4.91% | $301.83 (+19.18%) |
May 1, 2026 22w ago | Insider Cluster | $227.44 $221.41 | ▼ −2.65% | ▼ −5.00% | $301.83 (+32.71%) |
Apr 14, 2026 24w ago | Press Release | $232.34 $226.67 | ▼ −2.44% | ▼ −3.83% | $301.83 (+29.91%) |
Feb 26, 2026 31w ago | 8-K | $196.17 $206.27 | ▲ +5.15% | ▲ +6.28% | $301.83 (+53.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access